NSE: KMCSHIL · BSE: 524520 · ISIN INE879K01018
K M C Speciality Hospitals (India) Limited stock analysis
K M C Speciality Hospitals (India) Limited ranks #134 in the TickerSutra evidence-ranked universe with a score of 71/100 and 95% data confidence. The latest captured fundamentals show ROCE of 26.0%, quarterly sales growth of 37.9% and quarterly profit growth of 119.8%.Watchlist candidate
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- ROCE is 26%
- Strong CFO/EBITDA of 0.9×
- 25.2% three-year sales CAGR
- No promoter shares are reported as pledged
Risks and constraints
- Valuation is above 40× earnings
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹136cr | ₹37cr | ₹24cr | 28.0% |
| 2023 | ₹156cr | ₹42cr | ₹27cr | 27.0% |
| 2024 | ₹177cr | ₹48cr | ₹30cr | 27.0% |
| 2025 | ₹232cr | ₹57cr | ₹21cr | 25.0% |
| 2026 | ₹306cr | ₹88cr | ₹47cr | 29.0% |
| TTM | ₹331cr | ₹100cr | ₹56cr | 30.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
MANAGEMENT COMMENTARY
Signals from filed documents
16.64 Cr • Revenue from operations:: Rs. 73 Lakh • Institutional/community partnerships: 20 Natural • Total water consumed: 2,25,668 kL • Total energy consumed: 1,64,61,345.60 MJ • Renewable energy consumed: 1,51,46,643.60 MJ Human • Total workforce: 1695 • Doctors: 170+ • Nurses: 450+ Capacity Expansion Building the infrastructure required to serve more patients. Cutting-Edge Technology Relevant technologies support
The details of contracts or arrangements or transactions not at Arm's length basis and the details of material contracts or arrangements or transactions at Arm's length basis entered during the financial year are given in this report as Annexure 1 in AOC-2. The policy on dealing with Related Party Transactions as approved by the Board is available on the Company's website and the same can be accessed at http://www.ka
Source: IBEF Healthcare update November 2025 and Press information Bureau update March 2026. OPPORTUNITIES AND THREATS: Opportunities: • Rising income level • Greater health awareness • Increased precedence of lifestyle diseases • Improved access to health insurance coverage • Opportunity for horizontal and vertical growth • Growing elderly population, changing disease patterns • Encouraging avenues for attracting pr
The facility of participation at the AGM through VC/OAVM will be made available to at least 1000 members on first come first served basis. This will not include large Shareholders (Shareholders holding 2% or more shareholding), Promoters, Institutional Investors, Directors, Key Managerial Personnel, the Chairperson of the Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee,
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…